The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking Through Critical Synthesis Bottlenecks
Jason Lehmann, PhD, Senior Product Marketing Manager at Telesis Bio
What if it were possible to build, clone, and amplify candidate sequence constructs hands-free overnight? Join us to learn how Telesis Bio’s automated BioXp synthetic biology solutions are designed to help you break free from traditional lead synthesis bottlenecks and significantly accelerate your antibody discovery pipeline. Our automated benchtop BioXp system is designed to help scientists streamline biologics workflows by empowering:
Accelerated discovery: On-demand overnight synthesis of a variety of DNA constructs utilized across antibody development workflowsImproved productivity: Focus on strategic science by eliminating hands-on molecular biology benchwork with push-button automationConsolidated workflows: Build on your schedule while maintaining chain of custody of critical proprietary reagents
Jason is a senior product marketing manager at Telesis Bio. Prior to Telesis Bio he served as the product manager for immunoassays at BioLegend. He completed his doctoral studies in the Biomedical Sciences graduate program at the University of California, San Diego. Jason also completed a post-doctoral fellowship at the Emerging Pathogens Institute at the University of Florida.
